Latest news with #FY2024
Al-Ahram Weekly
5 days ago
- Business
- Al-Ahram Weekly
CBE sells €591.7 mln in T-bills at 2.25% yield - Economy
The Central Bank of Egypt (CBE) announced on Monday it sold €591.7 million in euro-denominated treasury bills (T-bills) at a weighted average yield of 2.25 percent, in an issuance conducted on behalf of the Ministry of Finance to help finance the state's budget deficit. According to CBE data, 26 bids were submitted by banks and institutions for a total of €726.7 million, with an average yield request of 2.36 percent. The ministry accepted around 20 bids, securing the targeted €591.7 million. T-bills are short-term government debt instruments, typically maturing within three to twelve months. The sale comes as Egypt's external debt rose to $155.2 billion in the first quarter of FY2024/2025, up from $152.8 billion in the final quarter of FY2023/2024. The government projects the public debt-to-GDP ratio will fall to 90 percent in FY2025/2026, which began on 1 July, compared to an average of 81–82 percent in recent fiscal years, citing measures to reduce domestic borrowing costs. Egypt's FY2025/2026 budget estimates total financing needs at EGP 3.6 trillion, up from EGP 2.8 trillion in the current fiscal year. Follow us on: Facebook Instagram Whatsapp Short link:
Business Times
27-07-2025
- Business
- Business Times
AEM Holdings CEO Amy Leong resigns
[SINGAPORE] Semiconductor testing equipment manufacturer AEM Holdings has announced the resignation of its chief executive officer Amy Leong, which took effect on Sunday (Jul 27). Leong, who held the post for slightly more than a year, will be replaced by Samer Kabbani, the group's president and chief technology officer, from Monday. In a regulatory filing on Sunday evening, AEM cited 'board-led leadership realignment for growth' as the reason for Leong's resignation. The filing indicated that there are no unresolved differences in opinion on material matters between Leong and the board of directors, including matters that would have a material impact on the group or its financial reporting. Loke Wai San has been AEM's chairman since 2011. He is also the founder and CEO of private equity fund adviser Novo Tellus Capital Partners. Kabbani has been with AEM since 2020. He was previously executive vice-president at Advantest and Astronics Test Systems, respectively. In his 14-year tenure at Cohu, Kabbani served in key senior management roles, including Delta Design Systems president. He is a 'prolific innovator with more than 30 registered patents in areas of advanced thermal management, photoresist processing, factory automation, and vision alignment and inspection', as described on the AEM website. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up In May, AEM reported a 42.9 per cent year-on-year rise in its bottom line for the first quarter of FY2025 ended March, as net profit margin improved. The group announced a net profit of S$3.3 million, translating to a margin of 3.9 per cent for the period, compared with S$2.3 million and 2.5 per cent, respectively, for the first quarter of FY2024. However, revenue was 8.7 per cent lower at S$86 million against S$94.2 million for the year-ago period. AEM said this was in line with its first-half revenue guidance of S$155 million to S$170 million, despite the uncertainty created by the tariff turmoil. The company said then that it is on track with its revenue diversification efforts, as revenue from new customers in its Test Cell Solutions segment doubled that of the previous quarter. AEM closed at S$1.72 on Friday, up S$0.03 or 1.8 per cent.
Yahoo
13-07-2025
- Business
- Yahoo
H2G Green Full Year 2025 Earnings: S$0.27 loss per share (vs S$0.005 loss in FY 2024)
Revenue: S$15.5m (up 52% from FY 2024). Net loss: S$3.84m (loss narrowed by 34% from FY 2024). S$0.27 loss per share. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period H2G Green's share price is broadly unchanged from a week ago. You still need to take note of risks, for example - H2G Green has 4 warning signs we think you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13-07-2025
- Business
- Yahoo
H2G Green Full Year 2025 Earnings: S$0.27 loss per share (vs S$0.005 loss in FY 2024)
Revenue: S$15.5m (up 52% from FY 2024). Net loss: S$3.84m (loss narrowed by 34% from FY 2024). S$0.27 loss per share. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period H2G Green's share price is broadly unchanged from a week ago. You still need to take note of risks, for example - H2G Green has 4 warning signs we think you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
13-07-2025
- Business
- Yahoo
iWOW Technology Full Year 2025 Earnings: S$0.007 loss per share (vs S$0.01 profit in FY 2024)
Revenue: S$34.6m (down 24% from FY 2024). Net loss: S$1.81m (down by 170% from S$2.58m profit in FY 2024). S$0.007 loss per share (down from S$0.01 profit in FY 2024). This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. All figures shown in the chart above are for the trailing 12 month (TTM) period iWOW Technology's share price is broadly unchanged from a week ago. We should say that we've discovered 2 warning signs for iWOW Technology (1 doesn't sit too well with us!) that you should be aware of before investing here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
